Search results for "Heart failure"
More clarity on myocarditis with mRNA COVID-19 vaccines
The classic presentation for COVID-19 vaccine-associated myocarditis is chest pain one to seven days after vaccination, with a median time of three days after vaccination, particularly after the second dose.
https://immattersacp.org/archives/2023/02/more-clarity-on-myocarditis-with-mrna-covid-19-vaccines.htm
1 Feb 2023
Watching weight for women
This month's issue addresses weight gain in women, celiac disease, and mRNA COVID-19 vaccines and myocarditis.
https://immattersacp.org/archives/2023/02/watching-weight-for-women.htm
1 Feb 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2023
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/12/13/1.htm
13 Dec 2022
New trials provide data to improve medication management in hypertension
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
https://immattersacp.org/weekly/archives/2022/10/18/6.htm
18 Oct 2022
MKSAP Quiz: Follow-up visit for chronic hypertension
A 44-year-old woman is evaluated during a follow-up visit for chronic hypertension. Over the past month, her average blood pressure measured with home blood pressure monitoring was 150/90 mm Hg. Following a physical exam and lab tests, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/10/11/3.htm
11 Oct 2022
Telmisartan does not improve walking performance in PAD
A randomized double-blind trial compared the angiotensin-receptor blocker with placebo in patients with peripheral artery disease (PAD) and found no difference in six-minute walk distance over six months.
https://immattersacp.org/weekly/archives/2022/10/11/2.htm
11 Oct 2022
Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find
A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://immattersacp.org/weekly/archives/2022/09/27/4.htm
27 Sep 2022
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Help COPD patients with more probing care
Patients with undiagnosed chronic obstructive pulmonary disease (COPD) can sometimes hide in plain sight.
https://immattersacp.org/archives/2022/09/help-copd-patients-with-more-probing-care.htm
1 Sep 2022